Ali Imran Amjad - Concepedia

Author

Ali Imran Amjad

University of Pittsburgh ORCID

Also Known As

A. Amjad, Ali Amjad, Ali I Amjad, Ali I. Amjad, Ali Imran Amjad, Amjad Ali, Amjad Ali (51075), Arfa Amjad, Asra Amjad

Publications

552

Citations

H-Index

Concepts

All Affiliations

University of Pittsburgh The University of Texas MD Anderson Cancer Center University of Pittsburgh Medical Center UPMC Hillman Cancer Center Bloomberg (United States)

About

Ali Imran Amjad is an author at University of Pittsburgh specializing in medicine, cancer research, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	223
2	Health Sciences	3	3	126
3	Cell Biology	1	1	18
4	Emergency Medicine	1	1	79
5	Family Medicine	1	1	79

Ali Imran Amjad

Publications

497

Citations

H-Index

Page 1

	Year	Citations
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses Ronan J. Kelly, Blair V. Landon, Ali H. Zaidi, Nature Medicine	2024	95
Autologous Hematopoietic Stem Cell Transplantation May Reverse Renal Failure in Patients with Multiple Myeloma Gaurav Parikh, Ali Imran Amjad, Rima M. Saliba, Biology of Blood and Marrow Transplantation	2009	80
Violence and Abuse Faced by Junior Physicians in the Emergency Department from Patients and Their Caretakers: A Nationwide Study from Pakistan Nabil Mahmood Mirza, Ali Imran Amjad, Abu Bakar Hafeez Bhatti, Journal of Emergency Medicine Family MedicineAbuse FacedEmergency CareEmergency Medicine TraumaEmergency Department	2011	79
Broccoli-Derived Sulforaphane and Chemoprevention of Prostate Cancer: From Bench to Bedside Ali Imran Amjad, Rahul Atul Parikh, Leonard J. Appleman, Current Pharmacology Reports UrologyOncologyChemoprevention StrategyMedicineFrom Bench	2015	65
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Low Left Ventricular Ejection Fraction Muzaffar H. Qazilbash, Ali Imran Amjad, S. Qureshi, Biology of Blood and Marrow Transplantation	2009	43
Neoadjuvant nivolumab plus concurrent chemoradiation in stage II/III esophageal/gastroesophageal junction cancer. Ronan J. Kelly, Kellie N. Smith, Valsamo Anagnostou, Journal of Clinical Oncology Induction NivolumabSurgical OncologyEsophageal CancerGastroenterologyPathology	2019	35
Predictors of prolonged survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma Qaiser Bashir, Hassan Khan, Robert Z. Orlowski, American Journal of Hematology	2011	27
CXCR4 Is a Novel Target of Cancer Chemopreventative Isothiocyanates in Prostate Cancer Cells Kozue Sakao, Avani R. Vyas, Sreenivasa R. Chinni, Cancer Prevention Research Cxcr4 LigandChemoprevention StrategyCxcr4 Protein LevelProstate Cancer CellsCxcr4 Expression	2015	18
Opana-ER used the wrong way: intravenous abuse leading to microangiopathic hemolysis and a TTP-like syndrome Ali Imran Amjad, Rahul Atul Parikh Blood	2013	16
De novo primary squamous cell carcinoma of the ovary: a case of a rare malignancy with an aggressive clinical course. Ali Imran Amjad, Inam Pal PubMed Surgical OncologyRare MalignancyTumoral PathologySquamous Cell CarcinomaMedicine	2008	14

Page 1